MedWatch

Coloplast boss after DKK 400 million hit: "When you predict these amounts, that entails a degree of estimation"

Coloplast had to include an extraordinary loss of DKK 400 million (USD 59.4 million) in its year-end statement due to court cases in the USA. Financial director Anders Lonning-Skovgaard is "very satisfied" with the accounts, but cannot say for sure whether the court case expenses have been paid.

Anders Lonning-Skovgaard, financial director at Coloplast, says that the calculations of how much money to set aside for US court case settlements are "based on a number of estimates and assumptions." Photo: Photo: Niels Hougaard/Ritzau Finans

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles